| Non-Small Cell Lung Cancer |
1 |
1 |
| Lung Cancer |
0 |
0.9 |
| Biologic Therapy |
0 |
0.71 |
| Metastasis |
0 |
0.6 |
| Brain Metastasis |
0 |
0.58 |
| Head and Neck Cancer |
0 |
0.57 |
| Lung Metastases |
0 |
0.57 |
| Antibody Drug Conjugates |
0 |
0.99 |
| Chemotherapy |
0 |
0.39 |
| Platinum |
0 |
0.39 |
| Hodgkin Lymphoma |
0 |
0.31 |
| Cancer |
0 |
0.3 |
| Lung |
0 |
0.3 |
| Small Cell Lung Cancer |
0 |
0.3 |
| Interstitial Lung Disease |
0 |
0.28 |
| Biomarker |
0 |
0.2 |
| Brain |
0 |
0.2 |
| Tumor |
0 |
0.2 |
| Tyrosine Kinase Inhibitor |
0 |
0.14 |
| Central Nervous System |
0 |
0.1 |
| Immunoglobulin A (IgA) |
0 |
0.1 |
| Immunotherapy |
0 |
0.1 |
| Monoclonal Antibody |
0 |
0.1 |
| New York |
0 |
0.1 |
| Patient History |
0 |
0.1 |
| Prognosis |
0 |
0.1 |
| Salvage Therapy |
0 |
0.1 |
| Tyrosine Kinase |
0 |
0.1 |